Meeder Advisory Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.33M | Buy |
44,870
+1,511
| +3% | +$280K | 0.43% | 38 |
|
|
2025
Q1 | $9.08M | Buy |
43,359
+4,375
| +11% | +$917K | 0.54% | 34 |
|
|
2024
Q4 | $6.93M | Sell |
38,984
-138
| -0.4% | -$24.5K | 0.43% | 38 |
|
|
2024
Q3 | $7.73M | Buy |
39,122
+1,173
| +3% | +$232K | 0.5% | 33 |
|
|
2024
Q2 | $6.51M | Buy |
37,949
+8,353
| +28% | +$1.43M | 0.46% | 35 |
|
|
2024
Q1 | $5.39M | Buy |
29,596
+1,006
| +4% | +$183K | 0.55% | 29 |
|
|
2023
Q4 | $4.43M | Buy |
28,590
+546
| +2% | +$84.6K | 0.51% | 32 |
|
|
2023
Q3 | $4.18M | Sell |
28,044
-3,978
| -12% | -$593K | 0.53% | 34 |
|
|
2023
Q2 | $4.31M | Sell |
32,022
-3,064
| -9% | -$413K | 0.46% | 38 |
|
|
2023
Q1 | $5.59M | Buy |
35,086
+2,441
| +7% | +$389K | 0.64% | 26 |
|
|
2022
Q4 | $5.28M | Buy |
+32,645
| New | +$5.28M | 0.67% | 26 |
|